Day: September 12, 2016

Athersys Announces Acceptance by PMDA of Clinical Trial Notification in Japan for Treatment of Ischemic Stroke With MultiStem®

CLEVELAND, Sept. 12, 2016 (GLOBE NEWSWIRE) — Athersys, Inc. (Nasdaq:ATHX) announced today the successful completion of Japan’s Pharmaceutical and Medical Devices Agency (PMDA) review of the Clinical Trial Notification (CTN), allowing the commencement by HEALIOS K.K. (Healios) of a confirmatory clinical trial evaluating the safety and efficacy of administration of MultiStem®, Athersys’ novel cell therapy product, for the treatment of ischemic stroke in Japan (also designated by Healios as HLCM051 in Japan).  In accordance with the regulatory system in Japan, a CTN is equivalent to an Investigational New Drug application, or IND, under the regulatory system used in the United

Neurostimulation Devices Market Worth $9.8 Billion By 2024: Grand View Research, Inc.

San Francisco, Sept. 12, 2016 (GLOBE NEWSWIRE) — The neurostimulation devices market is expected to reach USD 9.8 billion by 2024, according to a new report by Grand View Research, Inc. The neurostimulation devices market is anticipated to witness a significant growth during the study period from 2016 to 2024. This growth is majorly attributed to high prevalence of chronic diseases, including migraine and epilepsy. Increasing adoption of unhealthy lifestyle, diet, and growth in aging population is resulting in a growing incidence of the chronic disease in individuals. However, adverse effects and risks associated with neurostimulation devices and presence of stringent

China Antiscalant market To Reach $555.6 Million By 2024: Grand View Research, Inc.

San Francisco, Sept. 12, 2016 (GLOBE NEWSWIRE) — The China antiscalant market is expected to reach USD 555.6 million by 2024, according to a new report by Grand View Research, Inc. Antiscalants are used in applications where water with heavy metals comes in contact with surfaces causing scales, thereby, reducing the overall efficiency of the equipment and damaging the manufactured goods. The increasing use of antiscalants in coal gasification, power generation, and chemical plants to maintain efficient functioning of machinery will fuel industry expansion. Moreover, development of these end-use sectors on account of rapid industrialization and urbanization is expected to contribute

Sunesis Presents Dose Escalation Results from the Phase 1A Healthy Volunteer Study Evaluating Oral Non-Covalent BTK inhibitor SNS-062

SOUTH SAN FRANCISCO, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced results from the Company’s Phase 1A study in healthy volunteers evaluating oral non-covalent BTK inhibitor SNS-062. The study demonstrated a favorable safety, pharmacokinetic (PK) and pharmacodynamic (PD) profile for SNS-062 in healthy subjects. The results were presented on Saturday, September 10th at the European School of Haematology’s (ESH) 2nd International Conference on New Concepts in B-Cell Malignancies at the Estoril Congress Centre in Estoril, Portugal. “Our first-in-human clinical results are encouraging and reinforce our belief that SNS-062 has the potential to become an important

Arcadis Finds New York City Earns Most Sustainable US City

HIGHLANDS RANCH, Colo., Sept. 12, 2016 (GLOBE NEWSWIRE) — New York City leads the United States for sustainability, according to the Sustainable Cities Index from Arcadis, the leading global design and consultancy for natural and built assets. From 22 North American cities measured, New York City ranks ahead of Boston (5th), San Francisco (6th) and Seattle (7th) while rounding out the bottom rankings are Indianapolis, Tampa and Detroit. Canadian cities ranked ahead of most U.S. cities, with Vancouver taking the highest spot and Toronto and Montreal ranking in the top five. With cities home to more than half the world’s

Amarin’s REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee

BEDMINSTER, N.J. and DUBLIN, Ireland, Sept. 12, 2016 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) announced that, as expected, the independent data monitoring committee (DMC) has completed its review of the first pre-specified interim efficacy analysis for the REDUCE-IT cardiovascular outcomes study and has recommended that the trial continue as planned without modification. The 8,175-patient outcomes study is evaluating whether treatment with Vascepa® (icosapent ethyl) reduces cardiovascular events in patients who despite stabilized statin therapy have elevated triglyceride levels and other cardiovascular risk factors. In accordance with the study protocol, the first interim efficacy analysis was performed after adjudication of

Beverage Packaging Market value to reach USD 138.7 Billion in 2021 – Zion Market Research

Sarasota, FL, Sept. 12, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Beverage Packaging Market (Bottle, Can, Pouch, and Carton), By Material (Glass, Plastic, Metal, and Paperboard), for Alcoholic, Non-Alcoholic, and Dairy Applications: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”. According to the report, global demand for beverage packaging market was valued at USD 108.4 billion in 2015, is expected to reach USD 138.7 billion in 2021 and is anticipated to grow at a CAGR of 4.2% between 2016 and 2021. Packaging plays an important role in the

SDI Media Appoints Mark Howorth to CEO Position

Los Angeles, Sept. 12, 2016 (GLOBE NEWSWIRE) — SDI Media is pleased to announce the appointment of Mark Howorth as its new CEO. Mark has an impressive resume with extensive experience inside and outside the media and entertainment industry, most recently as COO of Panavision, the leading global provider of cameras and lenses for the motion picture and television industries. Prior to Panavision, Mark served as CEO of National Mobile Television, one of the largest providers of television trucks/OB vans to the live broadcast industry.  Additionally, Mark spent 15 years at the prestigious strategic management consultancy firm Bain & Company,

TPI Composites Inc. Names Ramesh Gopalakrishnan Vice President of Technology, Transfer & Launch

SCOTTSDALE, Ariz., Sept. 12, 2016 (GLOBE NEWSWIRE) — TPI Composites, Inc. (“TPI”) (Nasdaq:TPIC), a leading global wind blade manufacturer, today announced the hiring of Ramesh Gopalakrishnan as the organization’s new Vice President, Technology, Transfer & Launch. “We are very pleased to welcome Ramesh Gopalakrishnan to the TPI Composites executive team,” said Steve Lockard, TPI Composites president and CEO. “With over 20 years of experience in global composites engineering and manufacturing, Ramesh brings an impressive background, and we look forward to his leadership and expertise playing a role in our future growth plans.” In his most recent position before joining TPI,